Clindamycin enhances opsonization of Staphylococcus aureus

Area of Science:

• Microbiology
• Immunology
• Pharmacology

Background:

• Staphylococcus aureus is a significant human pathogen.
• Understanding host-pathogen interactions is crucial for developing effective treatments.
• Antibiotic sub-MIC (sub-minimal inhibitory concentration) effects on bacterial virulence are an area of active research.

Purpose of the Study:

• To investigate the effect of sub-MIC clindamycin on the phagocytosis of Staphylococcus aureus by human polymorphonuclear leukocytes.
• To elucidate the mechanisms underlying any observed changes in phagocytosis, focusing on opsonization and complement activation.

Main Methods:

• Staphylococcus aureus 502A was cultured with sub-MIC clindamycin.
• Phagocytosis assays were performed using human polymorphonuclear leukocytes.
• Opsonization kinetics were assessed using a chemiluminescence assay.
• Complement activation and C3b deposition were measured.
• Bacterial cell wall alterations were examined via electron microscopy.

Main Results:

• Phagocytosis of clindamycin-treated Staphylococcus aureus by polymorphonuclear leukocytes was significantly enhanced (P < 0.001).
• Clindamycin treatment led to more rapid opsonization and required lower serum concentrations for sufficient opsonization.
• Complement consumption and C3b fixation to the bacterial surface were accelerated.
• Electron microscopy revealed alterations in the Staphylococcus aureus cell wall following clindamycin exposure.

Conclusions:

• Sub-minimal inhibitory concentrations of clindamycin enhance the phagocytosis of Staphylococcus aureus.
• Clindamycin treatment promotes bacterial opsonization and complement activation, facilitating immune clearance.
• Alterations in the bacterial cell wall induced by clindamycin likely contribute to these enhanced immune responses.